Emphasizing economics and practicality, this panel will explore several key questions: What is the “value” to taxpayers for NIH-funded research that translates into early-stage life-sciences products, and should such funding impact pricing? How does the COVID pandemic, rapid vaccine development process, and related funding infusion impact economic and societal viewpoints on the core question? Should…